Feb 27, 2020 - Momenta (MNTA) reports mixed Q4 results, with a wider-than-expected loss and revenues beating the same.
Feb 24, 2020 - A generic approval for Perrigo of Teva's ProAir HFA was highly anticipated.
Feb 24, 2020 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Bayer Aktiengesellschaft, Pfizer, Mylan N.V. and Teva Pharmaceutical Industries
Feb 24, 2020 - Berkshire Hathaway's two pure-play pharmaceutical investments are far risker than its other holdings.
Feb 24, 2020 - The U.S. Food and Drug Administration approves Teva's (NYSE:TEVA) ArmonAir Digihaler (fluticasone propionate) Inhalation Powder, and inhaled coriticosteroid delivered via Teva's Digihaler device.Armon
Feb 21, 2020 - Emergent's (EBS) earnings lag estimates in Q4 while revenues surpass the mark.
Feb 21, 2020 - The global reliance on China for APIs and drug manufacturing might hit supply chains and production amid the Coronavirus outbreak. Thus, companies independent of China's input are up for grabs now.
Feb 20, 2020 - The stocks making the biggest moves in premarket trading include ViacomCBS, E-Trade, Zillow, IMAX, and more.
Feb 19, 2020 - It's a disappointing setback for a drug that has received previous approvals for similar conditions.
Feb 19, 2020 - Teva exceeded market expectations in the fourth quarter.Prospects continue to improve, driven by strong generic pipeline and two drugs.Fair value on Teva stock modelled.